Cargando…
Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
Aims: The short QT syndrome type 1 (SQT1) is linked to hERG channel mutations (e.g., N588K). Drug effects on hERG channel gating kinetics in SQT1-cells have not been investigated. Methods: This study used hiPSC-CMs of a healthy donor and a SQT1-patient carrying the N588K mutation and patch clamp to...
Autores principales: | Huang, Mengying, Liao, Zhenxing, Li, Xin, Yang, Zhen, Fan, Xuehui, Li, Yingrui, Zhao, Zhihan, Lang, Siegfried, Cyganek, Lukas, Zhou, Xiaobo, Akin, Ibrahim, Borggrefe, Martin, El-Battrawy, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138577/ https://www.ncbi.nlm.nih.gov/pubmed/34025432 http://dx.doi.org/10.3389/fphar.2021.675003 |
Ejemplares similares
-
Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019) -
Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022) -
Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Lan, Huan, et al.
Publicado: (2020) -
Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018) -
Lipopolysaccharide Modifies Sodium Current Kinetics through ROS and PKC Signalling in Induced Pluripotent Stem-Derived Cardiomyocytes from Brugada Syndrome Patient
por: Liao, Zhenxing, et al.
Publicado: (2022)